Dividend Daily RSS Feed RSS
Dividend Stocks

The Dividend Daily

Dividend stocks - News, notes, updates, and analysis, delivered fresh daily

Citigroup Boosts Price Target on Allergan (AGN)

By
February 7th, 2013

Citigroup Boosts Price Target on Allergan (AGN)

Try Dividend.com Premium for FREE »

On Thursday analysts at Citigroup increased the price target on healthcare company Allergan, Inc. (AGN) citing continuous double digit growth in its core businesses.

The analysts back a “Buy” rating on AGN and now see shares reaching $124. This target suggests a 14% upside to Wednesday’s closing price of $108.53.

Allergan shares were down $1.44, or -1.36%, during morning trading on Thursday. The stock is up about 23% over the past year.

The Bottom Line
Shares of Allergan (AGN) have a dividend yield of 0.19% based on Thursday’s intraday trading price of $107.37 and the company’s annualized dividend payout of 20 cents per share.

Allergan, Inc. (AGN) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

5 Rules of Winning Dividend Investing

FREE Dividend Stock Newsletter

Get the Dividend.com email newsletter to receive:

  • A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
  • Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
  • Tons of great market analysis and recommendations

Your Email

No Thanks

Free Dividend Newsletter

Get free dividend tips, analysis and updates straight to your inbox

Most Popular Articles MOST POPULAR ARTICLES ON DIVIDEND.COM
Comments on this Article COMMENTS ON THIS ARTICLE

Comments are closed.

About This Article ABOUT THIS ARTICLE

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Disclaimer: Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.